What is the current Price Target for the Capricor Therapeutics, Inc. stock?

The average Capricor Therapeutics, Inc. target price is $16.32. This is 110.58% higher than the current stock price. The highest price target is 631.61%, the lowest is -34.84%. 8 Analysts have issued a price target Capricor Therapeutics, Inc. 2027 .

How high will the Capricor Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Capricor Therapeutics, Inc. stock will rise. The performance of stocks, including the Capricor Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Capricor Therapeutics, Inc. stock today?

The performance of Capricor Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Capricor Therapeutics, Inc. stock fall?

The decline in Capricor Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Capricor Therapeutics, Inc. Forecast, price target & analysts

$7.75

0.39%

Nasdaq, Oct 06, 04:28 pm EDT.

ISIN

US14070B1017

Symbol

CAPR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Capricor Therapeutics, Inc. Target price 2026 - Analyst rating & recommendation

Capricor Therapeutics, Inc. Classifications & Recommendation

Buy

44%

Hold

56%

Capricor Therapeutics, Inc. Price Target

Target Price	$16.32
Price	$7.75
Potential	110.58% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Capricor Therapeutics, Inc. 2027 . The average Capricor Therapeutics, Inc. target price is $16.32. This is 110.58% register free of charge higher than the current stock price. The highest price target is $56.70 631.61% register free of charge , the lowest is $5.05 34.84% register free of charge .
	A rating was issued by 16 analysts: 7 Analysts recommend Capricor Therapeutics, Inc. to buy, 9 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Capricor Therapeutics, Inc. stock has an average upside potential 2027 of 110.58% register free of charge . Most analysts recommend the Capricor Therapeutics, Inc. stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.26	-1.81
	96.52%	19.91%
P/E		negative
EV/Sales		2.08

11 Analysts have issued a Capricor Therapeutics, Inc. forecast for earnings per share. The average Capricor Therapeutics, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.26	96.52%
2026	$-1.81 19.91% unlock
2027	$-1.35 25.41% unlock
2028	$-0.19 85.93% unlock
2029	$4.37 2,400.00% unlock
2030	$6.78 55.15% unlock
2031	$10.43 53.83% unlock
2032	$13.06 25.22% unlock
2033	$16.04 22.82% unlock

Current	-3.48	27.76%
2026	-4.29 23.44% unlock
2027	-5.73 33.57% unlock
2028	-40.70 610.30% unlock
2029	1.78 104.37% unlock
2030	1.14 35.96% unlock
2031	0.74 35.09% unlock
2032	0.59 20.27% unlock
2033	0.48 18.64% unlock

Capricor Therapeutics, Inc....

Current Capricor Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
B. Riley Securities	Locked ➜ Locked	Locked	Sep 14 2026
Piper Sandler	Locked ➜ Locked	Locked	Sep 01 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Aug 14 2026
Jones Trading	Locked ➜ Locked	Locked	Jul 31 2026
Piper Sandler	Locked ➜ Locked	Locked	Jul 30 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 30 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Jul 30 2026

Analyst Rating	Date
Locked B. Riley Securities: Locked ➜ Locked	Sep 14 2026
Locked Piper Sandler: Locked ➜ Locked	Sep 01 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Aug 14 2026
Locked Jones Trading: Locked ➜ Locked	Jul 31 2026
Locked Piper Sandler: Locked ➜ Locked	Jul 30 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 30 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Jul 30 2026

Discover more stocks with a high price target

NIO ADR 80.99%

Alibaba Group Holding Ltd 80.17%

Rheinmetall 71.25%

Tencent Holdings Ltd. 61.51%

Adyen 55.29%

Uber Technologies 49.13%

BYD 48.99%

TUI 42.81%

Infineon 42.72%

Siemens Energy 41.82%

Adidas 40.54%

Netflix 40.33%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now